Advanced search
Publication Cover
Clinical Toxicology Volume 57, 2019 - Issue 6
Submit an article Journal homepage
277
Views
6
CrossRef citations to date
0
Altmetric
Original Scientific Contributions

A novel synthetic cannabinoid (Cumyl-4-cyano-BINACA) resulting in hyperthermia, rhabdomyolysis, and renal failure in a 29-year-old patient: it’s not meningitisFootnote*

Tharwat El ZahranDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA; Correspondence[email protected]
,
Roy GeronaClinical Toxicology and Environmental Biomonitoring Laboratory, University of California, San Francisco, CA, USA
,
Brent W. MorganDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA;
&
Adam C. PomerleauDepartment of Emergency Medicine, Emory University School of Medicine, Atlanta, GA, USA;
Pages 421-422 | Received 20 Aug 2018, Accepted 07 Oct 2018, Published online: 15 Nov 2018

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Piotr Adamowicz. (2021) Blood concentrations of synthetic cannabinoids. Clinical Toxicology 59:3, pages 246-251.
Read now

Articles from other publishers (5)

Sara Malaca, Francesco P. Busardò, Giulio Nittari, Ascanio Sirignano & Giovanna Ricci. (2022) Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review on the Latest Insights. Current Pharmaceutical Design 28:32, pages 2603-2617.
Crossref
Amanda L A Mohr, Barry K Logan, Melissa F Fogarty, Alex J Krotulski, Donna M Papsun, Sherri L Kacinko, Marilyn A Huestis & Jeri D Ropero-Miller. (2022) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review. Journal of Analytical Toxicology 46:6, pages e116-e185.
Crossref
Michael B. Gatch, Andrew Tourigny, Ritu A. Shetty & Michael J. Forster. (2021) Behavioral pharmacology of five novel synthetic cannabinoids. Behavioural Pharmacology 33:2&3, pages 175-183.
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor & Samuel D. Banister. (2019) CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist. Frontiers in Pharmacology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.